Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer

Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer

US Patent 7514570 · Granted Apr 7, 2009

Estimated economic value: $7,190,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid forms of selective androgen receptor modulators2024
Solid forms of selective androgen receptor modulators2021
Solid forms of selective androgen receptor modulators2015
Solid forms of selective androgen receptor modulators2013
Solid forms of selective androgen receptor modulators2011
Solid forms of selective androgen receptor modulators2011
5-heteroaryl thiazoles and their use as PI3K inhibitors2011
Pyrazole derivatives as GnRH inhibitors2007
Pyrazole derivatives as GnRH inhibitors2007
Indole derivatives with vascular damaging activity2006
Benzoxazinone derivatives for use in the treatment of angiogenesis2005
Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necr2001